SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 231.29 |
| Enterprise Value ($M) | 231.29 |
| Book Value ($M) | 0.00 |
| Book Value / Share | 0.00 |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | 0.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | 0.00 |
| Return on Equity (ROE) | 0.00 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.00 |
| Assets | 0.00 |
| Liabilities | 0.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | State Street Corp | 1.80 | -75.28 | |
| 13G | Alyeska Investment Group, L.P. | 6.32 | ||
| 13G/A | PFM Health Sciences, LP | 1.90 | ||
| 13G | Granahan Investment Management Inc/ma | 7.38 | ||
| 13G/A | Tang Capital Partners Lp | 0.90 | -63.33 | |
| 13G/A | Vanguard Group Inc | 4.61 | 105.69 | |
| 13G | Goldman Sachs Group Inc | 6.40 | ||
| 13G/A | BlackRock Inc. | 4.70 | 21.93 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 829,508 | 2,839,068 | 29.22 | |
| 892,667 | 2,989,215 | 29.86 | |
| 1,245,095 | 4,013,860 | 31.02 | |
| 1,120,266 | 4,124,643 | 27.16 | |
| 645,076 | 2,671,128 | 24.15 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BDTX – Black Diamond Therapeutics, Inc. | BEAM – Beam Therapeutics Inc. |
| BIIB – Biogen Inc. | BMEA – Biomea Fusion, Inc. |
| BMRN – BioMarin Pharmaceutical Inc. |
Financial data and stock pages provided by
Fintel.io